Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Pulmonary Hypertension

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 61 articles:
HTML format
Text format



Single Articles


    May 2019
  1. KIM B, Arany Z
    Does Glycine cataBOLAsm Drive Pulmonary Hypertension?
    Circulation. 2019;139:2256-2259.
    PubMed     Text format    


    April 2019
  2. MARON BA, Ryan JJ
    A Concerning Trend for Patients With Pulmonary Hypertension in the Era of Evidence-Based Medicine.
    Circulation. 2019;139:1861-1864.
    PubMed     Text format    


    February 2019
  3. YU Q, Tai YY, Tang Y, Zhao J, et al
    BOLA3 Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension.
    Circulation. 2019 Feb 14. doi: 10.1161/CIRCULATIONAHA.118.035889.
    PubMed     Text format     Abstract available


    January 2019

  4. Correction to: Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.
    Circulation. 2019;139:e1.
    PubMed     Text format    


    August 2018
  5. BONNET S, Paulin R, Boucherat O
    Small SeP or Giant Leap for Pulmonary Hypertension Research?
    Circulation. 2018;138:624-626.
    PubMed     Text format    


    May 2018
  6. HADINNAPOLA C, Graf S, Morrell NW
    Response by Hadinnapola et al to Letter Regarding Article, "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension".
    Circulation. 2018;137:2413-2414.
    PubMed     Text format    


  7. HERNANDEZ-GONZALEZ I, Navas P, Escribano-Subias P
    Letter by Hernandez-Gonzalez et al Regarding Article, "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension".
    Circulation. 2018;137:2411-2412.
    PubMed     Text format    


  8. WHITE RJ, Wilkins MR
    New Therapeutic Approaches in Pulmonary Arterial Hypertension: The Pantheon Is Getting Crowded.
    Circulation. 2018;137:2390-2392.
    PubMed     Text format    


    April 2018
  9. LEOPOLD JA
    Pulmonary Venous Remodeling in Pulmonary Hypertension: The Veins Take Center Stage.
    Circulation. 2018;137:1811-1813.
    PubMed     Text format    


    February 2018
  10. HEMNES AR, Brittain EL
    Autonomic Nervous System in Pulmonary Arterial Hypertension: Time to Rest and Digest.
    Circulation. 2018;137:925-927.
    PubMed     Text format    


  11. RUBIN LJ
    Assessing Prognosis of Pulmonary Arterial Hypertension in the Therapeutic Era: Importance of Serial Hemodynamic Measurements.
    Circulation. 2018;137:705-706.
    PubMed     Text format    


    December 2017
  12. ARCHER SL
    Pyruvate Kinase and Warburg Metabolism in Pulmonary Arterial Hypertension: Uncoupled Glycolysis and the Cancer-Like Phenotype of Pulmonary Arterial Hypertension.
    Circulation. 2017;136:2486-2490.
    PubMed     Text format    


  13. FAYYAZ AU, Edwards WD, Maleszewski JJ, Konik EA, et al
    Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated with Heart Failure and Preserved or Reduced Ejection Fraction.
    Circulation. 2017 Dec 15. pii: CIRCULATIONAHA.117.031608.
    PubMed     Text format     Abstract available


    November 2017
  14. DA SILVA GONCALVES BOS D, Van Der Bruggen CE, Kurakula K, Sun XQ, et al
    Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    Circulation. 2017 Nov 22. pii: CIRCULATIONAHA.117.027451.
    PubMed     Text format     Abstract available


  15. CULLEY MK, Chan SY
    Human Endogenous Retrovirus K and Pulmonary Arterial Hypertension: A New Take on a Retro Idea.
    Circulation. 2017;136:1936-1938.
    PubMed     Text format    


    October 2017
  16. WEATHERALD J, Boucly A, Chemla D, Savale L, et al
    The Prognostic Value of Follow-up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Circulation. 2017 Oct 25. pii: CIRCULATIONAHA.117.029254.
    PubMed     Text format     Abstract available


    September 2017
  17. HADINNAPOLA C, Bleda M, Haimel M, Screaton N, et al
    Phenotypic Characterisation of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically with Pulmonary Arterial Hypertension.
    Circulation. 2017 Sep 28. pii: CIRCULATIONAHA.117.028351.
    PubMed     Text format     Abstract available


  18. ZHANG H, Wang D, Li M, Plecita-Hlavata L, et al
    The Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension is Regulated through a MiR-124/PTBP1/PKM Axis.
    Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028069.
    PubMed     Text format     Abstract available


  19. CARUSO P, Dunmore BJ, Schlosser K, Schoors S, et al
    Identification of miR-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 and PKM2.
    Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028034.
    PubMed     Text format     Abstract available


  20. SAITO T, Miyagawa K, Chen SY, Tamosiuniene R, et al
    Upregulation of HERV-K is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension.
    Circulation. 2017 Sep 21. pii: CIRCULATIONAHA.117.027589.
    PubMed     Text format     Abstract available


    July 2017
  21. LEISEGANG MS, Fork C, Josipovic I, Richter FM, et al
    Long Noncoding RNA MANTIS Facilitates Endothelial Angiogenic Function.
    Circulation. 2017;136:65-79.
    PubMed     Text format     Abstract available


    March 2017
  22. HWANGBO C, Lee HW, Kang H, Ju H, et al
    Modulation of Endothelial BMPR2 Activity by VEGFR3 in Pulmonary Arterial Hypertension.
    Circulation. 2017 Mar 29. pii: CIRCULATIONAHA.116.025390.
    PubMed     Text format     Abstract available


    February 2017
  23. CHEN J, Sysol JR, Singla S, Zhao S, et al
    Nicotinamide Phosphoribosyltransferase Promotes Pulmonary Vascular Remodeling and is a Therapeutic Target in Pulmonary Arterial Hypertension.
    Circulation. 2017 Feb 15. pii: CIRCULATIONAHA.116.024557.
    PubMed     Text format     Abstract available


    January 2017
  24. YANG P, Read C, Kuc RE, Buonincontri G, et al
    Elabela/Toddler is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of its Expression in Pulmonary Arterial Hypertension.
    Circulation. 2017 Jan 30. pii: CIRCULATIONAHA.116.023218.
    PubMed     Text format     Abstract available


    December 2016
  25. INAMI T, Kataoka M, Yanagisawa R, Ishiguro H, et al
    Long-Term Outcomes After Percutaneous Transluminal Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
    Circulation. 2016;134:2030-2032.
    PubMed     Text format    


    November 2016
  26. RHODES CJ, Ghataorhe P, Wharton J, Rue-Albrecht KC, et al
    Plasma Metabolomics Implicate Modified Transfer RNAs and Altered Bioenergetics in the Outcome of Pulmonary Arterial Hypertension.
    Circulation. 2016 Nov 21. pii: CIRCULATIONAHA.116.024602.
    PubMed     Text format     Abstract available


    August 2016
  27. VAN DER BRUGGEN CE, Happe CM, Goumans MJ, Bogaard HJ, et al
    Response by van der Bruggen et al to Letter Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
    Circulation. 2016;134:e117-8.
    PubMed     Text format    


  28. KATAOKA M, Satoh T, Fukuda K
    Letter by Kataoka et al Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
    Circulation. 2016;134:e115-6.
    PubMed     Text format    


  29. LI M, Riddle S, Zhang H, D'Alessandro A, et al
    Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Co-Repressor C-terminal Binding Protein-1.
    Circulation. 2016 Aug 25. pii: CIRCULATIONAHA.116.023171.
    PubMed     Text format     Abstract available


  30. LAI YC, Gladwin MT
    Response by Lai and Gladwin to Letter Regarding Article, "SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fractio
    Circulation. 2016;134:e79-80.
    PubMed     Text format    


  31. CARLSTROM M, Lundberg JO
    Letter by Carlstrom and Lundberg Regarding Article, "SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction".
    Circulation. 2016;134:e77-8.
    PubMed     Text format    


    July 2016
  32. SHAH SJ, Kitzman DW, Borlaug BA, van Heerebeek L, et al
    Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.
    Circulation. 2016;134:73-90.
    PubMed     Text format     Abstract available


    May 2016
  33. PRESTON IR, Roberts KE, Miller DP, Sen GP, et al
    Response to Letter Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)".
    Circulation. 2016;133:e662.
    PubMed     Text format    


  34. NIKPOUR M, Prior D, Celermajer D
    Letter by Nikpour et al Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)".
    Circulation. 2016;133:e661.
    PubMed     Text format    


  35. MARON BA
    Independence Day: Separating Right Ventricular Function from Pulmonary Arterial Hypertension in Systemic Sclerosis.
    Circulation. 2016 May 11. pii: CIRCULATIONAHA.116.023237.
    PubMed     Text format     Abstract available


  36. HSU S, Houston BA, Tampakakis E, Bacher AC, et al
    Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension.
    Circulation. 2016 May 11. pii: CIRCULATIONAHA.116.022082.
    PubMed     Text format     Abstract available


  37. CANNON JE, Su L, Kiely DG, Page K, et al
    Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort.
    Circulation. 2016;133:1761-71.
    PubMed     Text format     Abstract available


  38. STENMARK KR, Frid M, Perros F
    Endothelial-to-Mesenchymal Transition: An Evolving Paradigm and a Promising Therapeutic Target in PAH.
    Circulation. 2016;133:1734-7.
    PubMed     Text format    


    April 2016
  39. DAI Z, Li M, Wharton J, Zhu MM, et al
    PHD2 Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans through HIF-2alpha.
    Circulation. 2016 Apr 25. pii: CIRCULATIONAHA.116.021494.
    PubMed     Text format     Abstract available


  40. HOEPER MM
    Residual Pulmonary Hypertension After Pulmonary Endarterectomy: The Fog is Clearing.
    Circulation. 2016 Apr 6. pii: CIRCULATIONAHA.116.022595.
    PubMed     Text format     Abstract available


  41. HOPPER RK, Moonen JA, Diebold I, Cao A, et al
    In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and its Target Slug.
    Circulation. 2016 Apr 4. pii: CIRCULATIONAHA.115.020617.
    PubMed     Text format     Abstract available


    March 2016
  42. CHIU P, Irons M, van de Rijn M, Liang DH, et al
    Giant Pulmonary Artery Aneurysm in a Patient With Marfan Syndrome and Pulmonary Hypertension.
    Circulation. 2016;133:1218-21.
    PubMed     Text format    


  43. BRITTAIN EL, Talati M, Fessel JP, Zhu H, et al
    Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension.
    Circulation. 2016 Mar 22. pii: CIRCULATIONAHA.115.019351.
    PubMed     Text format     Abstract available


  44. VAN DER BRUGGEN CE, Happe CM, Dorfmuller P, Trip P, et al
    Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.
    Circulation. 2016 Mar 16. pii: CIRCULATIONAHA.115.020696.
    PubMed     Text format     Abstract available


    February 2016
  45. ANTIGNY F, Hautefort A, Meloche J, Belacel-Ouari M, et al
    Potassium-Channel Subfamily K-Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
    Circulation. 2016 Feb 24. pii: CIRCULATIONAHA.115.020951.
    PubMed     Text format     Abstract available


  46. HSU S, Kass DA
    Can Nitrite AMPk Up Sirt-ainty to Treat Heart Failure With Preserved Ejection Fraction?
    Circulation. 2016;133:692-4.
    PubMed     Text format    


  47. MARON BA, Hess E, Maddox TM, Opotowsky AR, et al
    Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the VA-CART Program.
    Circulation. 2016 Feb 12. pii: CIRCULATIONAHA.115.020207.
    PubMed     Text format     Abstract available


    January 2016
  48. DELCROIX M, Lang I, Pepke-Zaba J, Jansa P, et al
    Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Results From an International Prospective Registry.
    Circulation. 2016 Jan 29. pii: CIRCULATIONAHA.115.016522.
    PubMed     Text format     Abstract available


  49. LAI YC, Tabima DM, Dube JJ, Hughan KS, et al
    SIRT3-AMPK Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF).
    Circulation. 2016 Jan 26. pii: CIRCULATIONAHA.115.018935.
    PubMed     Text format     Abstract available


  50. CHEN X, Talati M, Fessel JP, Hemnes AR, et al
    Estrogen Metabolite 16alpha-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism.
    Circulation. 2016;133:82-97.
    PubMed     Text format     Abstract available


    December 2015
  51. WAXMAN AB, Farber HW
    Using Clinical Trial End Points to Risk Stratify Patients With Pulmonary Arterial Hypertension.
    Circulation. 2015;132:2152-61.
    PubMed     Text format    


    November 2015
  52. ABMAN SH, Hansmann G, Archer SL, Ivy DD, et al
    Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.
    Circulation. 2015 Nov 3. pii: CIR.0000000000000329.
    PubMed     Text format     Abstract available


    October 2015
  53. PRESTON IR, Roberts KE, Miller DP, Sen GP, et al
    Effect of Warfarin Treatment on Survival of Patients with Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL).
    Circulation. 2015 Oct 28. pii: CIRCULATIONAHA.115.018435.
    PubMed     Text format     Abstract available


    September 2015
  54. MOHAMMED SF, Forfia P, Redfield MM
    Response to Letter Regarding Article, "Right Ventricular Function in Heart Failure With Preserved Ejection Fraction: A Community-Based Study".
    Circulation. 2015;132:e161.
    PubMed     Text format    


  55. GUAZZI M
    Letter by Guazzi Regarding Article, "Right Ventricular Function in Heart Failure With Preserved Ejection Fraction: A Community-Based Study".
    Circulation. 2015;132:e160.
    PubMed     Text format    


  56. LAU EM, Montani D, Jais X, Sitbon O, et al
    Response to Letter Regarding Article, "Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension".
    Circulation. 2015;132:e154.
    PubMed     Text format    


  57. BABU AS, Padmakumar R, Maiya AG
    Letter by Babu et al Regarding Article, "Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension".
    Circulation. 2015;132:e153.
    PubMed     Text format    


    July 2015
  58. POTUS F, Ruffenach G, Dahou A, Thebault C, et al
    Downregulation of miR-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension.
    Circulation. 2015 Jul 10. pii: CIRCULATIONAHA.115.016382.
    PubMed     Text format     Abstract available


    June 2015
  59. MARON BA, Leopold JA
    Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension.
    Circulation. 2015;131:2079-91.
    PubMed     Text format    


    November 2014
  60. CHATTERJEE N, Steiner J, Lewis GD
    It's Time to Look at Heart Failure with Preserved Ejection Fraction from the Right Side.
    Circulation. 2014 Nov 12. pii: CIRCULATIONAHA.114.013536.
    PubMed     Text format     Abstract available


  61. MOHAMMED SF, Hussain I, Abou Ezzeddine OF, Takahama H, et al
    Right Ventricular Function in Heart Failure with Preserved Ejection Fraction: A Community Based Study.
    Circulation. 2014 Nov 12. pii: CIRCULATIONAHA.113.008461.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: